1184 related articles for article (PubMed ID: 17087942)
21. Clinicopathological features of CpG island methylator phenotype-positive colorectal cancer and its adverse prognosis in relation to KRAS/BRAF mutation.
Lee S; Cho NY; Choi M; Yoo EJ; Kim JH; Kang GH
Pathol Int; 2008 Feb; 58(2):104-13. PubMed ID: 18199160
[TBL] [Abstract][Full Text] [Related]
22. Mutations in both KRAS and BRAF may contribute to the methylator phenotype in colon cancer.
Nagasaka T; Koi M; Kloor M; Gebert J; Vilkin A; Nishida N; Shin SK; Sasamoto H; Tanaka N; Matsubara N; Boland CR; Goel A
Gastroenterology; 2008 Jun; 134(7):1950-60, 1960.e1. PubMed ID: 18435933
[TBL] [Abstract][Full Text] [Related]
23. Colorectal cancer with mutation in BRAF, KRAS, and wild-type with respect to both oncogenes showing different patterns of DNA methylation.
Nagasaka T; Sasamoto H; Notohara K; Cullings HM; Takeda M; Kimura K; Kambara T; MacPhee DG; Young J; Leggett BA; Jass JR; Tanaka N; Matsubara N
J Clin Oncol; 2004 Nov; 22(22):4584-94. PubMed ID: 15542810
[TBL] [Abstract][Full Text] [Related]
24. Cyclin D1 is frequently overexpressed in microsatellite unstable colorectal cancer, independent of CpG island methylator phenotype.
Nosho K; Kawasaki T; Chan AT; Ohnishi M; Suemoto Y; Kirkner GJ; Fuchs CS; Ogino S
Histopathology; 2008 Nov; 53(5):588-98. PubMed ID: 18983468
[TBL] [Abstract][Full Text] [Related]
25. Rectal cancer profiling identifies distinct subtypes in India based on age at onset, genetic, epigenetic and clinicopathological characteristics.
Laskar RS; Ghosh SK; Talukdar FR
Mol Carcinog; 2015 Dec; 54(12):1786-95. PubMed ID: 25418895
[TBL] [Abstract][Full Text] [Related]
26. Clinicopathologic characteristics, CpG island methylator phenotype, and BRAF mutations in microsatellite-stable colorectal cancers without chromosomal instability.
Kakar S; Deng G; Sahai V; Matsuzaki K; Tanaka H; Miura S; Kim YS
Arch Pathol Lab Med; 2008 Jun; 132(6):958-64. PubMed ID: 18517279
[TBL] [Abstract][Full Text] [Related]
27. Comprehensive analysis of CpG island methylator phenotype (CIMP)-high, -low, and -negative colorectal cancers based on protein marker expression and molecular features.
Zlobec I; Bihl M; Foerster A; Rufle A; Lugli A
J Pathol; 2011 Nov; 225(3):336-43. PubMed ID: 21660972
[TBL] [Abstract][Full Text] [Related]
28. BRAF mutation, CpG island methylator phenotype and microsatellite instability occur more frequently and concordantly in mucinous than non-mucinous colorectal cancer.
Tanaka H; Deng G; Matsuzaki K; Kakar S; Kim GE; Miura S; Sleisenger MH; Kim YS
Int J Cancer; 2006 Jun; 118(11):2765-71. PubMed ID: 16381005
[TBL] [Abstract][Full Text] [Related]
29. Cytoplasmic localization of p27 (cyclin-dependent kinase inhibitor 1B/KIP1) in colorectal cancer: inverse correlations with nuclear p27 loss, microsatellite instability, and CpG island methylator phenotype.
Ogino S; Kawasaki T; Ogawa A; Kirkner GJ; Loda M; Fuchs CS
Hum Pathol; 2007 Apr; 38(4):585-92. PubMed ID: 17239930
[TBL] [Abstract][Full Text] [Related]
30. Prognostic significance of CpG island methylator phenotype and microsatellite instability in gastric carcinoma.
An C; Choi IS; Yao JC; Worah S; Xie K; Mansfield PF; Ajani JA; Rashid A; Hamilton SR; Wu TT
Clin Cancer Res; 2005 Jan; 11(2 Pt 1):656-63. PubMed ID: 15701853
[TBL] [Abstract][Full Text] [Related]
31. Comprehensive biostatistical analysis of CpG island methylator phenotype in colorectal cancer using a large population-based sample.
Nosho K; Irahara N; Shima K; Kure S; Kirkner GJ; Schernhammer ES; Hazra A; Hunter DJ; Quackenbush J; Spiegelman D; Giovannucci EL; Fuchs CS; Ogino S
PLoS One; 2008; 3(11):e3698. PubMed ID: 19002263
[TBL] [Abstract][Full Text] [Related]
32. Mucinous carcinomas of the colorectum have distinct molecular genetic characteristics.
Song GA; Deng G; Bell I; Kakar S; Sleisenger MH; Kim YS
Int J Oncol; 2005 Mar; 26(3):745-50. PubMed ID: 15703832
[TBL] [Abstract][Full Text] [Related]
33. Comparison of microsatellite instability, CpG island methylation phenotype, BRAF and KRAS status in serrated polyps and traditional adenomas indicates separate pathways to distinct colorectal carcinoma end points.
O'Brien MJ; Yang S; Mack C; Xu H; Huang CS; Mulcahy E; Amorosino M; Farraye FA
Am J Surg Pathol; 2006 Dec; 30(12):1491-501. PubMed ID: 17122504
[TBL] [Abstract][Full Text] [Related]
34. CpG island methylator phenotype associates with low-degree chromosomal abnormalities in colorectal cancer.
Cheng YW; Pincas H; Bacolod MD; Schemmann G; Giardina SF; Huang J; Barral S; Idrees K; Khan SA; Zeng Z; Rosenberg S; Notterman DA; Ott J; Paty P; Barany F
Clin Cancer Res; 2008 Oct; 14(19):6005-13. PubMed ID: 18829479
[TBL] [Abstract][Full Text] [Related]
35. Genetic and epigenetic classifications define clinical phenotypes and determine patient outcomes in colorectal cancer.
Sanchez JA; Krumroy L; Plummer S; Aung P; Merkulova A; Skacel M; DeJulius KL; Manilich E; Church JM; Casey G; Kalady MF
Br J Surg; 2009 Oct; 96(10):1196-204. PubMed ID: 19787768
[TBL] [Abstract][Full Text] [Related]
36. BRAF mutation is associated with DNA methylation in serrated polyps and cancers of the colorectum.
Kambara T; Simms LA; Whitehall VL; Spring KJ; Wynter CV; Walsh MD; Barker MA; Arnold S; McGivern A; Matsubara N; Tanaka N; Higuchi T; Young J; Jass JR; Leggett BA
Gut; 2004 Aug; 53(8):1137-44. PubMed ID: 15247181
[TBL] [Abstract][Full Text] [Related]
37. JC virus T-antigen in colorectal cancer is associated with p53 expression and chromosomal instability, independent of CpG island methylator phenotype.
Nosho K; Shima K; Kure S; Irahara N; Baba Y; Chen L; Kirkner GJ; Fuchs CS; Ogino S
Neoplasia; 2009 Jan; 11(1):87-95. PubMed ID: 19107235
[TBL] [Abstract][Full Text] [Related]
38. Concomitant RASSF1A hypermethylation and KRAS/BRAF mutations occur preferentially in MSI sporadic colorectal cancer.
Oliveira C; Velho S; Domingo E; Preto A; Hofstra RM; Hamelin R; Yamamoto H; Seruca R; Schwartz S
Oncogene; 2005 Nov; 24(51):7630-4. PubMed ID: 16007118
[TBL] [Abstract][Full Text] [Related]
39. CpG island methylator phenotype in colorectal cancers: comparison of the new and classic CpG island methylator phenotype marker panels.
Lee S; Cho NY; Yoo EJ; Kim JH; Kang GH
Arch Pathol Lab Med; 2008 Oct; 132(10):1657-65. PubMed ID: 18834226
[TBL] [Abstract][Full Text] [Related]
40. IGFBP3 promoter methylation in colorectal cancer: relationship with microsatellite instability, CpG island methylator phenotype, and p53.
Kawasaki T; Nosho K; Ohnishi M; Suemoto Y; Kirkner GJ; Fuchs CS; Ogino S
Neoplasia; 2007 Dec; 9(12):1091-8. PubMed ID: 18084616
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]